Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $INDV vs $MANE | Chartloom

Compare

$INDV vs $MANE

Indivior Pharmaceuticals, Inc · Veradermics Inc

INDV

Indivior Pharmaceuticals, Inc

MANE

Veradermics Inc

Compare $INDV vs $MANE

Comparing Indivior Pharmaceuticals, Inc and Veradermics Inc

INDVIndivior Pharmaceuticals, Inc

MANEVeradermics Inc

INDVIndivior Pharmaceuticals, Inc

Market cap

$4.29B

P/E (TTM)

12.37x

Forward P/E (NTM)

7.50x

Forward P/S (NTM)

3.13x

Rev growth (TTM)

13.6%

YTD performance

-0.9%

52W performance

48.9%

FCF yield

-2.5%

MANEVeradermics Inc

Market cap

$4.86B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

208.0%

52W performance

208.0%

FCF yield

-2.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

INDV

MANE

Detailed metrics comparison

INDV

Indivior Pharmaceuticals, Inc

MANE

Veradermics Inc

Market Cap

INDV$4.29B

MANE$4.86B

Enterprise Value

INDV$4.55B

MANE$4.54B

Price

INDV$35.42

MANE$116.26

P/E Ratio

INDV12.37x

MANEN/A

P/S Ratio

INDV3.22x

MANE0.00x

EV/Sales

INDV3.42x

MANE0.00x

EV/EBITDA

INDV10.26x

MANE0.00x

P/B Ratio

INDV422.91x

MANE6.72x

P/FCF Ratio

INDVN/A

MANEN/A

EV/FCF

INDV-41.75x

MANE-42.29x

PEG Ratio

INDV0.41x

MANEN/A

Forward P/E (NTM)

INDV7.50x

MANEN/A

Forward P/S (NTM)

INDV3.13x

MANEN/A

Revenue (TTM)

INDV$1.33B

MANE$0

Revenue Growth (YoY)

INDV13.6%

MANEN/A

Forward Rev Growth

INDV5.4%

MANE308.7%

Gross Margin (TTM)

INDV82.0%

MANE0.0%

Operating Margin (TTM)

INDV30.3%

MANE0.0%

EBITDA Margin (TTM)

INDV33.1%

MANE0.0%

Net Margin (TTM)

INDV26.7%

MANE0.0%

FCF Margin (TTM)

INDV-8.2%

MANEN/A

Net Income (TTM)

INDV$355M

MANE$-137M

FCF (TTM)

INDV$-109M

MANE$-107M

EPS (TTM)

INDV$2.86

MANE-$3.39

ROE (TTM)

INDV159.1%

MANE-3549.0%

ROA (TTM)

INDV28.1%

MANE-3463.0%

ROIC (TTM)

INDV29.4%

MANE-3549.0%

Cash

INDV$222M

MANE$319M

Debt

INDV$487M

MANE$0

Net Cash/Debt

INDV$-265M

MANE$319M

Current Ratio (TTM)

INDV0.84x

MANE70.53x

Quick Ratio (TTM)

INDV0.65x

MANE70.35x

Debt/Equity (TTM)

INDV27.90x

MANE0.00x

Debt/Assets (TTM)

INDV0.0%

MANE0.0%

Interest Coverage (TTM)

INDVN/A

MANEN/A

Net Debt/EBITDA (TTM)

INDV0.00x

MANE0.00x

Beta

INDV0.49

MANE-0.05

52W Performance

INDV48.9%

MANE208.0%

YTD Performance

INDV-0.9%

MANE208.0%

% from 52W High

INDV-17.3%

MANE-15.0%

% from 52W Low

INDV50.4%

MANE263.3%

Asset Turnover (TTM)

INDV1.06x

MANE0.00x

FCF Yield (TTM)

INDV-2.5%

MANE-2.2%

Earnings Yield (TTM)

INDV8.3%

MANE-2.8%

Dividend Yield (TTM)

INDVN/A

MANEN/A

Rule of 40

INDV5.4

MANE0.0

EV/GP/RG

INDV1.40

MANEN/A

Ticker research

View INDV research View MANE research

Metric	INDV Indivior Pharmaceuticals, Inc	MANE Veradermics Inc
Market & Valuation
Market Cap	$4.29B	$4.86B
Enterprise Value	$4.55B	$4.54B
Price	$35.42	$116.26
P/E Ratio	12.37x	N/A
P/S Ratio	3.22x	0.00x
EV/Sales	3.42x	0.00x
EV/EBITDA	10.26x	0.00x
P/B Ratio	422.91x	6.72x
P/FCF Ratio	N/A	N/A
EV/FCF	-41.75x	-42.29x
PEG Ratio	0.41x	N/A
Forward P/E (NTM)	7.50x	N/A
Forward P/S (NTM)	3.13x	N/A
Revenue & Growth
Revenue (TTM)	$1.33B	$0
Revenue Growth (YoY)	13.6%	N/A
Forward Rev Growth	5.4%	308.7%
Profitability
Gross Margin (TTM)	82.0%	0.0%
Operating Margin (TTM)	30.3%	0.0%
EBITDA Margin (TTM)	33.1%	0.0%
Net Margin (TTM)	26.7%	0.0%
FCF Margin (TTM)	-8.2%	N/A
Net Income (TTM)	$355M	$-137M
FCF (TTM)	$-109M	$-107M
EPS (TTM)	$2.86	-$3.39
ROE (TTM)	159.1%	-3549.0%
ROA (TTM)	28.1%	-3463.0%
ROIC (TTM)	29.4%	-3549.0%
Financial Health
Cash	$222M	$319M
Debt	$487M	$0
Net Cash/Debt	$-265M	$319M
Current Ratio (TTM)	0.84x	70.53x
Quick Ratio (TTM)	0.65x	70.35x
Debt/Equity (TTM)	27.90x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.49	-0.05
52W Performance	48.9%	208.0%
YTD Performance	-0.9%	208.0%
% from 52W High	-17.3%	-15.0%
% from 52W Low	50.4%	263.3%
Efficiency & Yields
Asset Turnover (TTM)	1.06x	0.00x
FCF Yield (TTM)	-2.5%	-2.2%
Earnings Yield (TTM)	8.3%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5.4	0.0
EV/GP/RG	1.40	N/A
Ticker research	View INDV research	View MANE research

Valuation

P/E Ratio

INDV

12.37x

P/S Ratio

MANE

0.00x

INDV

3.22x

EV/FCF

MANE

-42.29x

INDV

-41.75x

Growth & revenue

Revenue Growth TTM

INDV

13.6%

Forward Revenue Growth

MANE

308.7%

INDV

5.4%

Profitability & performance

Gross Margin

INDV

82.0%

MANE

0.0%

ROE

INDV

159.1%

MANE

-3549.0%

FCF Yield %

MANE

-2.2%

INDV

-2.5%

52-Week Performance

MANE

208.0%

INDV

48.9%

Detailed metrics comparison

INDV

Indivior Pharmaceuticals, Inc

MANE

Veradermics Inc

Market Cap

INDV$4.29B

MANE$4.86B

Enterprise Value

INDV$4.55B

MANE$4.54B

Price

INDV$35.42

MANE$116.26

P/E Ratio

INDV12.37x

MANEN/A

P/S Ratio

INDV3.22x

MANE0.00x

EV/Sales

INDV3.42x

MANE0.00x

EV/EBITDA

INDV10.26x

MANE0.00x

P/B Ratio

INDV422.91x

MANE6.72x

P/FCF Ratio

INDVN/A

MANEN/A

EV/FCF

INDV-41.75x

MANE-42.29x

PEG Ratio

INDV0.41x

MANEN/A

Forward P/E (NTM)

INDV7.50x

MANEN/A

Forward P/S (NTM)

INDV3.13x

MANEN/A

Revenue (TTM)

INDV$1.33B

MANE$0

Revenue Growth (YoY)

INDV13.6%

MANEN/A

Forward Rev Growth

INDV5.4%

MANE308.7%

Gross Margin (TTM)

INDV82.0%

MANE0.0%

Operating Margin (TTM)

INDV30.3%

MANE0.0%

EBITDA Margin (TTM)

INDV33.1%

MANE0.0%

Net Margin (TTM)

INDV26.7%

MANE0.0%

FCF Margin (TTM)

INDV-8.2%

MANEN/A

Net Income (TTM)

INDV$355M

MANE$-137M

FCF (TTM)

INDV$-109M

MANE$-107M

EPS (TTM)

INDV$2.86

MANE-$3.39

ROE (TTM)

INDV159.1%

MANE-3549.0%

ROA (TTM)

INDV28.1%

MANE-3463.0%

ROIC (TTM)

INDV29.4%

MANE-3549.0%

Cash

INDV$222M

MANE$319M

Debt

INDV$487M

MANE$0

Net Cash/Debt

INDV$-265M

MANE$319M

Current Ratio (TTM)

INDV0.84x

MANE70.53x

Quick Ratio (TTM)

INDV0.65x

MANE70.35x

Debt/Equity (TTM)

INDV27.90x

MANE0.00x

Debt/Assets (TTM)

INDV0.0%

MANE0.0%

Interest Coverage (TTM)

INDVN/A

MANEN/A

Net Debt/EBITDA (TTM)

INDV0.00x

MANE0.00x

Beta

INDV0.49

MANE-0.05

52W Performance

INDV48.9%

MANE208.0%

YTD Performance

INDV-0.9%

MANE208.0%

% from 52W High

INDV-17.3%

MANE-15.0%

% from 52W Low

INDV50.4%

MANE263.3%

Asset Turnover (TTM)

INDV1.06x

MANE0.00x

FCF Yield (TTM)

INDV-2.5%

MANE-2.2%

Earnings Yield (TTM)

INDV8.3%

MANE-2.8%

Dividend Yield (TTM)

INDVN/A

MANEN/A

Rule of 40

INDV5.4

MANE0.0

EV/GP/RG

INDV1.40

MANEN/A

Ticker research

View INDV research View MANE research

Metric	INDV Indivior Pharmaceuticals, Inc	MANE Veradermics Inc
Market & Valuation
Market Cap	$4.29B	$4.86B
Enterprise Value	$4.55B	$4.54B
Price	$35.42	$116.26
P/E Ratio	12.37x	N/A
P/S Ratio	3.22x	0.00x
EV/Sales	3.42x	0.00x
EV/EBITDA	10.26x	0.00x
P/B Ratio	422.91x	6.72x
P/FCF Ratio	N/A	N/A
EV/FCF	-41.75x	-42.29x
PEG Ratio	0.41x	N/A
Forward P/E (NTM)	7.50x	N/A
Forward P/S (NTM)	3.13x	N/A
Revenue & Growth
Revenue (TTM)	$1.33B	$0
Revenue Growth (YoY)	13.6%	N/A
Forward Rev Growth	5.4%	308.7%
Profitability
Gross Margin (TTM)	82.0%	0.0%
Operating Margin (TTM)	30.3%	0.0%
EBITDA Margin (TTM)	33.1%	0.0%
Net Margin (TTM)	26.7%	0.0%
FCF Margin (TTM)	-8.2%	N/A
Net Income (TTM)	$355M	$-137M
FCF (TTM)	$-109M	$-107M
EPS (TTM)	$2.86	-$3.39
ROE (TTM)	159.1%	-3549.0%
ROA (TTM)	28.1%	-3463.0%
ROIC (TTM)	29.4%	-3549.0%
Financial Health
Cash	$222M	$319M
Debt	$487M	$0
Net Cash/Debt	$-265M	$319M
Current Ratio (TTM)	0.84x	70.53x
Quick Ratio (TTM)	0.65x	70.35x
Debt/Equity (TTM)	27.90x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.49	-0.05
52W Performance	48.9%	208.0%
YTD Performance	-0.9%	208.0%
% from 52W High	-17.3%	-15.0%
% from 52W Low	50.4%	263.3%
Efficiency & Yields
Asset Turnover (TTM)	1.06x	0.00x
FCF Yield (TTM)	-2.5%	-2.2%
Earnings Yield (TTM)	8.3%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5.4	0.0
EV/GP/RG	1.40	N/A
Ticker research	View INDV research	View MANE research